chr18-31093631-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024422.6(DSC2):c.82G>T(p.Ala28Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000196 in 1,583,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.82G>T | p.Ala28Ser | missense_variant | 2/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.82G>T | p.Ala28Ser | missense_variant | 2/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.-348G>T | 5_prime_UTR_variant | 2/16 | NP_001393435.1 | |||
DSC2 | NM_001406507.1 | c.-348G>T | 5_prime_UTR_variant | 2/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.82G>T | p.Ala28Ser | missense_variant | 2/16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081.8 | c.82G>T | p.Ala28Ser | missense_variant | 2/17 | 1 | ENSP00000251081.6 | |||
DSC2 | ENST00000648081.1 | c.-385G>T | 5_prime_UTR_variant | 2/17 | ENSP00000497441.1 | |||||
DSC2 | ENST00000682357.1 | c.-348G>T | 5_prime_UTR_variant | 2/16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.0000867 AC: 13AN: 149956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249794Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135178
GnomAD4 exome AF: 0.0000126 AC: 18AN: 1433380Hom.: 0 Cov.: 30 AF XY: 0.00000981 AC XY: 7AN XY: 713340
GnomAD4 genome AF: 0.0000867 AC: 13AN: 149956Hom.: 0 Cov.: 32 AF XY: 0.0000548 AC XY: 4AN XY: 73024
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jan 07, 2013 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Based on the data reviewed below, we characterize this variant as a variant of uncertain significance. This variant has not been previously reported as a disease-causing mutation according to searches of PubMed and Google; it is present, however, in an African American population dataset. Variants in this gene can cause arrhythmogenic right ventricular cardiomyopathy (ARVC). This is a non-conservative amino acid change from a nonpolar alanine to a neutral, polar serine. It has a Grantham score of 99. The alanine at codon 28 is not well conserved across 30 vertebrate species examined (it is a serine in opossum, as in this patient, and a threonine in dog, kangaroo rat, and pika). In silico analysis with PolyPhen-2 (humVAR) predicts the variant to be “benign” with a score of 0.078; SIFT predicts it to be “tolerated” with a score of 0.830. In total this specific variant has been seen in 3 out of ~2500 African-American individuals from publicly available population datasets. It is present in 3/2203 African-American individuals in the NHLBI Exome Sequencing Project dataset, for an allele frequency of 0.07%. It was not present in 4300 European American individuals. This gives it an overall allele frequency in the ESP of 0.02%. It is present in dbSNP as rs139979318, submitted by the ESP. It is not present in 1000 genomes. (1000 genomes phase 1 is made up of 1092 individuals of various races, 246 of them with African or African-American ancestry). Presence of a variant among individuals in the general population cannot definitively rule it out as the cause of disease, as even gold-standard pathogenic cardiomyopathy variants have been found in population datasets (Pan et al. 2012). - |
Arrhythmogenic right ventricular dysplasia 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 28 of the DSC2 protein (p.Ala28Ser). This variant is present in population databases (rs139979318, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 234988). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DSC2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 07, 2023 | This missense variant replaces alanine with serine at codon 28 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with DSC2-related disorders in the literature. This variant has been identified in 5/280590 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Primary familial dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Mar 30, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2022 | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function - |
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Aug 06, 2024 | This missense variant replaces alanine with serine at codon 28 of the DSC2 protein. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant nor has this variant been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 5/280590 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 24, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at